Logo Cepheid
Poproś o informacje
Lokalizacja/język

{{headingText}}

{{paragraphText}}

{{continueBtnLabel}}
{{initials}}
Main Menu
Lokalizacja/język

{{headingText}}

{{paragraphText}}

{{continueBtnLabel}}

Poproś o informacje
Poproś o informacje
Community Global Health Light Hero Notxt image

Czas czytania: 5 min

27 marca 2026

ZDROWIE SPOŁECZNOŚCI I ZDROWIE GLOBALNE

Artykuł

Hepatitis C Elimination in the U.S. is Within Reach, Experts Report

Hepatitis C elimination in the U.S. is within reach—if we do three things: expand point‑of‑care testing, scale treatment access, and unify stakeholders for coordinated action, according to health economists Louis Garrison, Ph.D. and Bruce Wang, Ph.D. 

 

In a Viewpoint paper in JAMA Health Forum, the economists detail progress toward HCV elimination, including why "single-step HCV diagnosis is widely seen as a critical component of an HCV elimination program"1 and why U.S. policy makers should support the Cure Hepatitis C Act of 2025 (S.1941).

 

At Cepheid, we’re proud to support HCV elimination efforts by offering the Xpert® HCV test, which provides point‑of‑care molecular detection to help expand access to diagnosis.

 

Read the full paper JAMA Health Forum.

Image of the Viewpoint paper

IVD. Wyrób medyczny przeznaczony do diagnostyki in vitro. Produkt może nie być dostępny we wszystkich krajach.

 

1 Garrison LP, Wang BCM. Stakeholder Engagement for Hepatitis C Virus Elimination. JAMA Health Forum. 2026;7(1):e256433. doi:10.1001/jamahealthforum.2025.6433

Was this article helpful?

Czytaj dalej

WIĘCEJ

Powered by Translations.com GlobalLink Web SoftwarePowered by GlobalLink Web